← Leaderboards
Angela Michelle Carter
University Of Alabama At Birmingham
$1,265,190
Attributed
$2,780,750
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,780,750 · 3
By mechanism
R01$2,372,375 · 2
R21$408,375 · 1
Top collaborators
- Aurelio Antonio Galli4 shared
- Sadanandan E. Velu2 shared
- Ivet Bahar1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Aurelio Antonio Galli$19,438,938
- Heinrich J.g. Matthies$2,474,147
- Troy D Randall$33,910,350
- Christina A Muzny$5,578,242
- Janusz H Kabarowski$1,990,528
Others in their field
Other Rising Stars on “Translating”
- Gary Mays · Axle Informatics, Llc$88,671,397
- Mari Ostendorf · University Of Washington$51,931,230
- Brian Zavertnik · Palantir Technologies, Inc.$37,240,166
- Cyrus Wadia · Activate Global, Inc.$31,489,493
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Rashada Alexander · American Association For The Advancement Of Science$22,676,040
Research focus
TranslatingDopaminePreferenceRodentBehaviorDopamine TransporterDrosophila GenusPharmaceutical PreparationsProteinsPsychostimulantExtracellularAmphetaminesAmphetamine UseBrainAnimal ModelAffectIn VivoMolecularCessation Of LifeExperimental StudyDrosophila MelanogasterDrug Of AbuseDysbiosisAmphetamine Abuse
Grant awards (6)
The Role of HIV Proteins in Psychostimulant Abuse$751,112
R01 · FY2025 · DA
The Role of Microbiome Composition in Amphetamine Abuse$536,931
R01 · FY2025 · DA
Microbial Biofilms as Regulators of Amphetamine Use Disorders$222,750
R21 · FY2025 · DA · contact PI
The Role of Microbiome Composition in Amphetamine Abuse$542,166
R01 · FY2024 · DA
Microbial Biofilms as Regulators of Amphetamine Use Disorders$185,625
R21 · FY2024 · DA · contact PI
The Role of Microbiome Composition in Amphetamine Abuse$542,166
R01 · FY2023 · DA